Uganda Successfully Launches Trials For Coronavirus Drug
Uganda has launched clinical trials of a locally produced herbal treatment for COVID-19. The therapeutic drug was developed by a think-tank of local scientists - under the Presidential Initiative on Epidemics. The product: UBV-01N is the first Ugandan natural chemotherapeutic medicine to go through an international level of the clinical trial process. Michael Baleke reports from Kampala.
President Yoweri Kaguta launched the herbal treatment as Uganda’s first clinical trials for a coronavirus drug at Mulago Hospital in Kampala.
The president congratulated scientists involved in the breakthrough in the fight against the virus and pledged to prioritize the sector during his next term in office.
She said the country would be kept posted on the findings and the outcome of the studies, before thanking the President and other Ugandans who keep observing SoPs.
The presidential advisor on epidemics, Dr. Monica Musenero, said the researchers were working on even more products to treat viral and bacterial infections.
“I want to thank the team and we are looking forward to more innovative natural products that will make the country proud,” she said.
For this clinical trial, the drug will be administered to 128 male and female patients who will present Covid-19 symptoms at Mulago Hospital.